Form 4: Bio-Techne Corp Director Judith V. Klimovsky Acquires Shares and Stock Options

Director Judith V. Klimovsky reports acquisition of Bio-Techne Corp common stock and stock options.

Summary

• Judith V. Klimovsky, a director of Bio-Techne Corp, reported a transaction on May 1, 2024.
• She acquired 680 shares of common stock at $0 and 1,610 stock options with an exercise price of $73.46.
• The stock options vest on the earlier of May 1, 2025, or the date of Bio-Techne's annual meeting of shareholders.
• Following the transaction, Klimovsky directly owns 680 shares of common stock and 1,610 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option acquisitions by a director. While insider buying can be seen as positive, this is a standard transaction and doesn't necessarily indicate a strong bullish or bearish outlook.

Positives

• A director's acquisition of company stock and options can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future performance.

Stakeholder Impact

• The acquisition of shares and options by a director could have a slightly positive impact on shareholder sentiment.

Key Dates